SCHEMBL8952378

SCHEMBL8952378

CC(C)=CCC/C(C)=C/Cc1nc2c(c(=O)[nH]c(=O)n2C)n1C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.45
▸ HPGD P15428 4/20 0.45
▸ TSHR P16473 2/20 0.45
▸ MAPK1 P28482 8/20 0.44
▸ HSD17B10 Q99714 3/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ POLB P06746 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8952170 0.99 ALDH1A1 (0.44) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL8952374 0.77 ALDH1A1 (0.49) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL8952238 0.77 ALDH1A1 (0.49) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL8952332 0.75 ALDH1A1 (0.52) ALDH1A1HPGDMAPK1HSD17B10KDM4E
SCHEMBL8952243 0.75 ALDH1A1 (0.45) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL8952322 0.75 ALDH1A1 (0.45) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL515834 0.73 KDM4E (0.54) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL6948261 0.72 HSD17B10 (0.55) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL19013585 0.71 KDM4E (0.55) ALDH1A1HPGDTSHRMAPK1HSD17B10
SCHEMBL8952239 0.70 ALDH1A1 (0.50) ALDH1A1HPGDMAPK1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662834-A4 NOVEL EPOXIDE-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-17 — — EP disclosed
EP-0697873-A4 — — 1996-04-03 — — EP disclosed
EP-0697873-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1996-02-28 — — EP disclosed
EP-0662834-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-07-19 — — EP disclosed
WO-1994015606-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-07-21 — — WO disclosed
WO-1994006431-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-31 — — WO disclosed
Send feedback